Omar Cabahug — TMS Medicare billing
M.D. · Neurology · Henderson, NV
TMS provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Services (2024)
851
Patient bounds
27–48
Services per patient (bounds)
17.7–31.5
Estimated Medicare paid
$81,442
National provider median $51,810
National peer context
#83 of 391 published TMS providers by screening score/payment in 2024 · 0.23% of national published TMS payment. This rank is not a clinical assessment.
Peer evidence
Screening score 8 · Low; highest same-code/setting shared peer score, not a probability of fraud.
No threshold flags in the available same-code/setting comparisons. This is not a clearance.
No NPI match in the saved OIG LEIE copy—not a clearance.
Year-over-year Medicare payments
CMS billing detail — 2024
Fetched 2026-11-07T23:23:37.341Z · Complete three-code cohort
| Code / treatment | Services | Patient bounds | Services / patient | Medicare paid |
|---|---|---|---|---|
| 90867 Initial treatment + motor-threshold determination | 21 | 21–21 | 1.0–1.0 | $3,646 |
| 90868 Subsequent treatment | 830 | 27–27 | 30.7–30.7 | $77,796 |
Peer evidence
Screening score 8 · Low; highest same-code/setting shared peer score, not a probability of fraud.
No threshold flags in the available same-code/setting comparisons. This is not a clearance.
CMS billing detail — 2023
Fetched 2026-11-07T23:23:27.130Z · Complete three-code cohort
| Code / treatment | Services | Patient bounds | Services / patient | Medicare paid |
|---|---|---|---|---|
| 90867 Initial treatment + motor-threshold determination | 18 | 18–18 | 1.0–1.0 | $3,126 |
| 90868 Subsequent treatment | 1,021 | 31–31 | 32.9–32.9 | $94,895 |
Peer evidence
Screening score 12 · Low; highest same-code/setting shared peer score, not a probability of fraud.
No threshold flags in the available same-code/setting comparisons. This is not a clearance.
Medicare Part B fee-for-service only; Medicare Advantage, Medicaid and commercial claims are excluded. CMS suppresses provider-code rows with fewer than 11 beneficiaries. Patient counts overlap across codes and settings; bounds are not unique national patients. Annual aggregates cannot establish treatment courses, failure, medical necessity, duplicate visits or fraud. Coverage varies by Medicare contractor; no Spravato dosing thresholds are applied.
